Results 261 to 270 of about 163,730 (308)

Personalized Cancer Vaccines in Combination Therapies: Current Status and Future Prospects. [PDF]

open access: yesAsian Pac J Cancer Prev
Rukhayya F   +9 more
europepmc   +1 more source

Gut microbiota: a new factor modulating the immunizing potential of viral and cancer vaccines

open access: yes
Zitvogel L   +47 more
europepmc   +1 more source

Cancer Vaccines

open access: yesHematology/Oncology Clinics of North America, 2019
Cancer vaccines are a promising strategic approach within the rapidly growing field of immuno-oncology. Therapeutic cancer vaccines are distinct from prophylactic vaccines and vary by both target antigen and vaccine platform. There are currently 3 FDA-approved therapeutic cancer vaccines: intravesical BCG live, sipuleucel-T, and T-VEC.
Peter J, DeMaria, Marijo, Bilusic
openaire   +3 more sources

Cancer vaccines: the next immunotherapy frontier

open access: yesNature Cancer, 2022
Brody and colleagues discuss the current status and potential of cancer vaccines, highlighting challenges and opportunities to advance promising candidates to the clinic.
Matthew Lin   +2 more
exaly   +2 more sources

Cancer Vaccines

Current Protocols in Human Genetics, 1997
AbstractThis unit describes the use of retroviral vectors that can be successfully employed for gene transfer into both primary tumor cultures and established cell lines. The unit includes procedures for assaying the stability of the vaccine following gene transfer.
T F, Greten, E M, Jaffee
  +8 more sources

Cancer vaccines

Seminars in Oncology Nursing, 2003
To provide a review of cancer vaccines, how they work, and the current state of the science underlying these treatments.Research studies, review articles, book chapters, personal communications.Vaccines have been studied in a variety of malignancies; however, melanoma has provided the best tumor model for vaccination.
Paula M, Muehlbauer   +1 more
openaire   +4 more sources

Cancer vaccines

Vaccine, 2001
Cancer vaccines have been extensively tested in animal models, and in humans. Initial studies focused on first generation vaccines based on whole cell preparations or tumor lysates derived from autologous or allogeneic tumors. Clinical studies conducted with such candidate vaccines contributed to establish the feasibility of immunizing cancer patients ...
R F, Rousseau   +3 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy